- cafead   Jul 12, 2023 at 11:12: PM
via Clinical-stage biotech Recursion continues to go from strength to strength. After its recent acquisition of Cyclica and Valence, the company announced a partnership with—and $50 million investment from—NVIDIA on Wednesday.
article source
article source